Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Pannecouque

Showing results (101-110 of 427) with videos related to

Pageof 43
Sort By:
Chemistry & Biodiversity|December 29, 2006
Nitroimidazoles, part 2: Synthesis, antiviral and antitumor activity of new 4-nitroimidazolesNajim A Al-Masoudi, Yaseen A Al-Soud, Aris Kalogerakis, et al.
Bioorganic Chemistry|November 9, 2004
Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-onesYanping He, Fener Chen, Xiongjie Yu, et al.
Bioorganic Chemistry|May 19, 2019
Follow on-based optimization of the biphenyl-DAPYs as HIV-1 nonnucleoside reverse transcriptase inhibitors against the wild-type and mutant strainsYali Sang, Sheng Han, Shuwen Han, et al.
Bioorganic & Medicinal Chemistry|October 30, 2007
Synthesis and anti-HIV evaluation of novel 1,3-disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3H)-one 2,2-dioxides(TTDDs)Yongqiang Lin, Xinyong Liu, Renzhang Yan, et al.
European Journal of Medicinal Chemistry|November 28, 2022
Structure-guided design of novel HEPT analogs with enhanced potency and safety: From Isopropyl-HEPTs to Cyclopropyl-HEPTsRuo-Lan Zhou, Zhiran Ju, Christophe Pannecouque, et al.
Antiviral Chemistry & Chemotherapy|December 1, 2007
Isothiazole derivatives as antiviral agentsAdriana Garozzo, Christian C C Cutri, Christophe Pannecouque, et al.
European Journal of Medicinal Chemistry|September 28, 2021
Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channelXin Jin, Hu-Ri Piao, Christophe Pannecouque, et al.
Molecules (Basel, Switzerland)|March 1, 2020
Design of Biphenyl-Substituted Diarylpyrimidines with a Cyanomethyl Linker as HIV-1 NNRTIs via a Molecular Hybridization StrategyYuan Lei, Sheng Han, Yang Yang, et al.
European Journal of Medicinal Chemistry|July 7, 2022
Discovery of novel biphenyl-substituted pyridone derivatives as potent non-nucleoside reverse transcriptase inhibitors with promising oral bioavailabilityLi-Min Zhao, Shuai Wang, Christophe Pannecouque, et al.
Bioorganic & Medicinal Chemistry|June 1, 2017
Searching for novel N<sub>1</sub>-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitorsStefania Ferro, Maria Rosa Buemi, Laura De Luca, et al.
Pageof 43

Showing results (101-110 of 427) with videos related to

Sort By:
Pageof 43
Chemistry & Biodiversity|December 29, 2006
Nitroimidazoles, part 2: Synthesis, antiviral and antitumor activity of new 4-nitroimidazolesNajim A Al-Masoudi, Yaseen A Al-Soud, Aris Kalogerakis, et al.
Bioorganic Chemistry|November 9, 2004
Nonnucleoside HIV-1 reverse transcriptase inhibitors; part 3. Synthesis and antiviral activity of 5-alkyl-2-[(aryl and alkyloxyl-carbonylmethyl)thio]-6-(1-naphthylmethyl) pyrimidin-4(3H)-onesYanping He, Fener Chen, Xiongjie Yu, et al.
Bioorganic Chemistry|May 19, 2019
Follow on-based optimization of the biphenyl-DAPYs as HIV-1 nonnucleoside reverse transcriptase inhibitors against the wild-type and mutant strainsYali Sang, Sheng Han, Shuwen Han, et al.
Bioorganic & Medicinal Chemistry|October 30, 2007
Synthesis and anti-HIV evaluation of novel 1,3-disubstituted thieno[3,2-c][1,2,6]thiadiazin-4(3H)-one 2,2-dioxides(TTDDs)Yongqiang Lin, Xinyong Liu, Renzhang Yan, et al.
European Journal of Medicinal Chemistry|November 28, 2022
Structure-guided design of novel HEPT analogs with enhanced potency and safety: From Isopropyl-HEPTs to Cyclopropyl-HEPTsRuo-Lan Zhou, Zhiran Ju, Christophe Pannecouque, et al.
Antiviral Chemistry & Chemotherapy|December 1, 2007
Isothiazole derivatives as antiviral agentsAdriana Garozzo, Christian C C Cutri, Christophe Pannecouque, et al.
European Journal of Medicinal Chemistry|September 28, 2021
Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channelXin Jin, Hu-Ri Piao, Christophe Pannecouque, et al.
Molecules (Basel, Switzerland)|March 1, 2020
Design of Biphenyl-Substituted Diarylpyrimidines with a Cyanomethyl Linker as HIV-1 NNRTIs via a Molecular Hybridization StrategyYuan Lei, Sheng Han, Yang Yang, et al.
European Journal of Medicinal Chemistry|July 7, 2022
Discovery of novel biphenyl-substituted pyridone derivatives as potent non-nucleoside reverse transcriptase inhibitors with promising oral bioavailabilityLi-Min Zhao, Shuai Wang, Christophe Pannecouque, et al.
Bioorganic & Medicinal Chemistry|June 1, 2017
Searching for novel N<sub>1</sub>-substituted benzimidazol-2-ones as non-nucleoside HIV-1 RT inhibitorsStefania Ferro, Maria Rosa Buemi, Laura De Luca, et al.
Pageof 43